Latest articles

healthcare-life-sciences-pharma

Climate risk exposes adaptation gaps in pharma supply chains

Almost nine in ten pharmaceutical companies expect climate-related disruption to their supply chains to increase, but new research suggests practical adaptation remains limited and supplier visibility is still a significant barrier.

Register for free with StrategicRISK

Unlock full access to award-winning journalism tailored for senior risk professionals.

If you are already registered, please .